Definitive Healthcare Corp
For the period ended Mar 31, 2024. Filed May 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
ITEM 5. OTHER INFORMATION
Trading Arrangements
None.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On May 1, 2024, as part of its planning and organizational design with respect to its executive leadership team, the Company agreed with Jonathan Maack that the President position that he held would be eliminated. Accordingly, Mr. Maack will remain employed with the Company through May 31, 2024. Mr. Maack’s departure constitutes a termination of employment without “cause” for purposes of any employment, equity compensation, or benefit agreement, plan, or arrangement of the Company and its subsidiaries to which Mr. Maack is a party or otherwise participates. In addition, effective May 1, 2024, Kate Shamsuddin Jensen was appointed as the Company’s Chief Strategy Officer, transitioning from her prior role of Chief Product Officer.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.